Transmyocardial laser revascularisation for refractory angina pectoris

period 12 months; significance not stated). 2.4.3 An RCT of 100 patients reported that postoperative heart failure occurred more frequently in TMLR-treated patients (34% [17 of 50]) than in medically treated patients (0% [0 of 50]), but significance was not stated. An RCT of 182 patients reported that thromboembolic events occurred more frequently in TMLR-treated patients (10% [9 of 92]) than those treated medically (3% [3 of 90]), but significance and follow-up were not stated. 2.4.4 A case series of 169 TMLR-treated patients reported that 14% (23 of 169) developed acute non-inflammatory pericarditis following the procedure (sequelae not reported). In a case series of 20 TMLR-treated patients, acute mitral regurgitation was reported in 5% (1 of 20). An international multicentre case series of 932 patients reported cardiac tamponade in less than 1% (5 of 932) of patients. 2.4.5 A retrospective non-randomised controlled trial of 255 patients reported that neurological complications occurred more frequently after TMLR plus CABG (3% [1 of 36]) than after CABG alone (1% [3 of 219]), but significance and follow-up were not stated. 2.4.6 Specialist advisers stated that adverse events reported in the literature included death, myocardial infarction, heart failure, arrhythmias, and wound and other infections. 2.5
